Results vary by individual based on goals, lifestyle, and medical conditions
If you have symptoms of deficiency that have never been investigated, see your GP for a blood test before booking any injection
Dosing Considerations AOD-9604 has typically been administered: Subcutaneously In the low-milligram daily range Often pre-bedtime, consistent with endogenous GH circadian patterns In 812 week protocols Specific dosing depends on compounding pharmacy formulation
Hydroxocobalamin injections are the UK first-line treatment, administered intramuscularly to ensure reliable B12 delivery independent of gut absorption
The two peptides share a chain length but almost nothing else in terms of origin, receptor targets, or downstream signaling
AOD-9604 demonstrates selectivity for beta-3 receptors, which are predominantly expressed in adipose tissue